SCHEMBL1454677

SCHEMBL1454677

CCCCCC(C)(C)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
EPHX1 P07099 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 1/20 0.40
CACNA2D1 P54289 1/20 0.40
KCNH3 Q9ULD8 1/20 0.40
SIGMAR1 Q99720 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALOX12 P18054 1/20 0.37
CYP2C19 P33261 1/20 0.37
ICMT O60725 1/20 0.36
ALB P02768 1/20 0.36
SOAT2 O75908 1/20 0.36
SOAT1 P35610 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HDAC8 Q9BY41 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7174301 0.98 GAA (0.46) GAAEPHX1ALDH1A1HTTCACNA2D1
SCHEMBL1454049 0.98 GAA (0.46) GAAEPHX1ALDH1A1HTTCACNA2D1
SCHEMBL9146997 0.98 GAA (0.46) GAAEPHX1ALDH1A1HTTCACNA2D1
SCHEMBL11726260 0.93 MAPT (0.44) GAAALDH1A1HTTCACNA2D1KCNH3
SCHEMBL14840338 0.89 SOAT2 (0.52) GAASOAT2SOAT1MAPT
SCHEMBL21634339 0.87 MAPT (0.46) GAAALDH1A1HTTCACNA2D1KCNH3
SCHEMBL1453847 0.86 GAA (0.43) GAAALDH1A1CACNA2D1NPSR1ALOX12
SCHEMBL29769245 0.84 ESR1 (0.36) GAAHTTCACNA2D1MEN1KMT2A
SCHEMBL23633882 0.83 GAA (0.46) GAAEPHX1ALDH1A1HTTKCNH3
SCHEMBL25857253 0.83 GAA (0.46) GAAEPHX1ALDH1A1HTTKCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
US-7504510-B2 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. (US) 2009-03-17 US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed
US-20060173107-A1 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. 2006-08-03 US disclosed
EP-0327318-B1 Heat-sensitive recording materials FUJI PHOTO FILM CO LTD (JP) 1995-07-19 EP disclosed
EP-0327318-A2 Heat-sensitive recording materials FUJI PHOTO FILM CO., LTD. (JP) 1989-08-09 EP disclosed
EP-0288240-A2 Heat-sensitive diazo recording material FUJI PHOTO FILM CO., LTD. (JP) 1988-10-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173107-A1 Graftable hindered amine light stabilizers IDO1, MAOA, TPH1 GAA 1676/4885EPHX1 1057/4885ALDH1A1 50/4885
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 GAA 4257/4885EPHX1 3367/4885ALDH1A1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.